Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2011-05-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To estimate the role of morphological, clinical, biochemical and imaging studies at stages of kidney transplantation (medical therapy, explantation, preservation, transplantation).
* To improve the ways of preserving optimal functional parameters of renal transplants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China
NCT01796639
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
NCT06877169
NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation
NCT03866421
The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
NCT06577805
A Study of Retrograde Reperfusion of Renal Graft to Reduce Ischemic-reperfusion Injury
NCT05179434
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Transplantation of donor organs is the only radical treatment for various diseases of the terminal, for patients with a fatal prognosis.
Kidney transplantation has allowed not only save lives, but also to return to normal life, tens of thousands of people. Survival of renal transplant recipients is growing.
Despite the progress made in many clinics worldwide in recent years in the field of transplantation, kidney transplantation, does not settle the problem of reperfusion injury and the associated post-transplant dysfunction with the absence of clear indicators of morphological, clinical, biochemical and instrumental methods to assess functional reserve of organs that remain relevant and meaningful.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Kidney transplantation
Kidney transplantation from alive relative donor.
Kidney Transplantation from alive relative donor
Donor kidney sampling, preservation, transport and transplantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kidney Transplantation from alive relative donor
Donor kidney sampling, preservation, transport and transplantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* donor healthy people without absolute contraindications to the kidney transplantation;
* donor and recipients who are both in the genetic and non-genetic related to each other.
* obligatory immunological compatibility by HLA-phenotyping provided that the donor and recipient are not relatives with each other;
* negative result of cross-match between donors and recipients;
* presence of pre-existing lymphotoxic antibodies in a recipient less than 50%;
* absence of standard absolute contraindications in a donor and in a recipient for surgeric intervention.
Age is 18-60 years.
Exclusion Criteria
* immunological incompatibility between donor and recipient;
* high level of pre-existing lymphotoxic antibodies in a recipient more than 50%, uncorrected by Therapy;
* donor age is under 18 and over 60 years;
* incapable persons;
* absence of a notarized consent form to kidney transplantation;
* presence of the active phase of viral infection with hepatitis B and C;
* positive results of blood tests for HIV/AIDS, syphilis;
* patients with severe concomitant pathology of kidneys, (or) heart and (or)liver.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nazarbayev University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gani M Kuttymuratov, Phd
Role: PRINCIPAL_INVESTIGATOR
Advisor to the Board Chairman
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Republican Scientific Center for Emergency Medicine
Astana, , Kazakhstan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0111RK00337
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.